Cargando…
Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
Episodic ataxia type 2 (EA2) is an autosomal dominant neurological disorder characterized by paroxysmal attacks of ataxia, vertigo, and nausea that usually last hours to days. It is caused by loss-of-function mutations in CACNA1A, the gene encoding the pore-forming α(1) subunit of P/Q-type voltage-g...
Autores principales: | Jaudon, Fanny, Baldassari, Simona, Musante, Ilaria, Thalhammer, Agnes, Zara, Federico, Cingolani, Lorenzo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555146/ https://www.ncbi.nlm.nih.gov/pubmed/32899500 http://dx.doi.org/10.3390/biomedicines8090332 |
Ejemplares similares
-
Emerging Roles of Activity-Dependent Alternative Splicing in Homeostatic Plasticity
por: Thalhammer, Agnes, et al.
Publicado: (2020) -
Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
por: Thalhammer, Agnes, et al.
Publicado: (2018) -
CRISPR-mediated activation of autism gene Itgb3 restores cortical network excitability via mGluR5 signaling
por: Jaudon, Fanny, et al.
Publicado: (2022) -
Brain Organoids as Model Systems for Genetic Neurodevelopmental Disorders
por: Baldassari, Simona, et al.
Publicado: (2020) -
CRISPR-Mediated Activation of αV Integrin Subtypes Promotes Neuronal Differentiation of Neuroblastoma Neuro2a Cells
por: Riccardi, Sara, et al.
Publicado: (2022)